Cargando…
No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523265/ https://www.ncbi.nlm.nih.gov/pubmed/32993759 http://dx.doi.org/10.1186/s13054-020-03307-5 |
| _version_ | 1783588353639186432 |
|---|---|
| author | Bienvenu, Anne-Lise Bleyzac, Nathalie Richard, Jean-Christophe Leboucher, Gilles |
| author_facet | Bienvenu, Anne-Lise Bleyzac, Nathalie Richard, Jean-Christophe Leboucher, Gilles |
| author_sort | Bienvenu, Anne-Lise |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7523265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75232652020-09-29 No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment Bienvenu, Anne-Lise Bleyzac, Nathalie Richard, Jean-Christophe Leboucher, Gilles Crit Care Letter BioMed Central 2020-09-29 /pmc/articles/PMC7523265/ /pubmed/32993759 http://dx.doi.org/10.1186/s13054-020-03307-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter Bienvenu, Anne-Lise Bleyzac, Nathalie Richard, Jean-Christophe Leboucher, Gilles No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title | No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title_full | No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title_fullStr | No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title_full_unstemmed | No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title_short | No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients—think empirical treatment |
| title_sort | no time for pending confirmation of invasive fungal disease in critically ill covid-19 patients—think empirical treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523265/ https://www.ncbi.nlm.nih.gov/pubmed/32993759 http://dx.doi.org/10.1186/s13054-020-03307-5 |
| work_keys_str_mv | AT bienvenuannelise notimeforpendingconfirmationofinvasivefungaldiseaseincriticallyillcovid19patientsthinkempiricaltreatment AT bleyzacnathalie notimeforpendingconfirmationofinvasivefungaldiseaseincriticallyillcovid19patientsthinkempiricaltreatment AT richardjeanchristophe notimeforpendingconfirmationofinvasivefungaldiseaseincriticallyillcovid19patientsthinkempiricaltreatment AT lebouchergilles notimeforpendingconfirmationofinvasivefungaldiseaseincriticallyillcovid19patientsthinkempiricaltreatment |